|
|||||
|
|
| 转运体介导的甲氨蝶呤药物相互作用研究进展 | |
| 引用本文： | 付冉, 王小楠, 李亚静, 丁琮洋, 孟璐, 董占军. 转运体介导的甲氨蝶呤药物相互作用研究进展[J]. 中国现代应用药学, 2020, 37(21): 2684-2688. DOI: 10.13748/j.cnki.issn1007-7693.2020.21.022 |
| 作者姓名： | 付冉 王小楠 李亚静 丁琮洋 孟璐 董占军 |
| 作者单位： | 河北医科大学,河北医科大学,河北省人民医院,河北医科大学,河北医科大学,河北省人民医院 |
| 基金项目： | 2018年度河北省医学科学研究重点课题计划 |
| 摘 要： | 甲氨蝶呤是一种抗叶酸类抗肿瘤药物，临床常用于治疗某些肿瘤性疾病、风湿性关节炎和银屑病，治疗作用显著，但治疗窗较窄。多种转运体参与甲氨蝶呤在体内的处置过程，当甲氨蝶呤与其他药物合用时，易发生基于转运体的药物相互作用，从而导致药物的不良反应或药物疗效的改变。本文通过查阅及分析文献，总结归纳了转运体介导的甲氨蝶呤与其他药物间的相互作用，为甲氨蝶呤的临床合理用药提供参考。 |
| 关 键 词： | 甲氨蝶呤 药物相互作用 转运体 ATP结合盒转运蛋白 溶质转运蛋白 |
| 收稿时间： | 2019-09-11 |
| 修稿时间： | 2020-04-03 |
Advances in Transporter-mediated Drug Interactions with Methotrexate |
|
| FU Ran, WANG Xiaonan, LI Yajing, DING Congyang, MENG Lu, DONG Zhanjun. Advances in Transporter-mediated Drug Interactions with Methotrexate[J]. Chinese Journal of Modern Applied Pharmacy, 2020, 37(21): 2684-2688. DOI: 10.13748/j.cnki.issn1007-7693.2020.21.022 | |
| Authors: | FU Ran WANG Xiaonan LI Yajing DING Congyang MENG Lu DONG Zhanjun |
| Affiliation: | HeBei Medical University,HeBei Medical University,HeBei General Hospital,HeBei Medical University,HeBei Medical University,HeBei General Hospital |
| Abstract: | Methotrexate is an anti-folate antitumor drug, which is often used to treat cancer, rheumatoid arthritis and psoriasis.Methotrexate has a significant therapeutic effect, but its treatment window is narrow.Various transporters are involved in the disposal of methotrexate in vivo. When methotrexate is used in combination with other drugs, drug interactions based on transporters are likely to occur, leading to side effects or changes in efficacy.This paper summarized the transport-mediated drug-drug innteractions of methotrexate and strategies to the adverse reactions to provide references information for rational administration of medication in clinic. |
| Keywords: | methotrexate drug-drug interaction transporter ATP-binding cassette transporter solute carriers |
| 点击此处可从《中国现代应用药学》浏览原始摘要信息 | |
| 点击此处可从《中国现代应用药学》下载全文 | |